AI in drug discovery: Applications, opportunities, and challenges
Martin-Immanuel Bittner, Sahar Farajnia
Patterns · 2022
doi:10.1016/j.patter.2022.100529 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Artificial intelligence (AI) is an umbrella term for a whole host of different approaches and technologies that revolve around the use of advanced computational approaches that can emulate (parts of) human decision making. Today, the discipline within AI that receives most attention and acclaim is machine learning (ML), focused on enabling computers to learn from experience as opposed to following a direct programing that instructs them what to do. Over the past years, AI (and especially ML) has increasingly found its way into healthcare in general, and drug discovery and development in particular.
Abstract licence: CC BY-NC
Cited by papers we hold1
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.